Reimbursement and patient assistance programs for oral chemotherapy agents.
نویسنده
چکیده
Oncology nurses increasingly are being asked about medication insurance coverage for oral chemotherapy agents and other medications. In small clinic and office settings, nurses often are key providers of this information. Nurses need to be informed about Medicare's medication reimbursement guidelines and able to identify resources for patients. Resources may include pharmaceutical manufacturers, patient medication assistance programs, and medication discount programs. This article reviews these resources and provides tips to use them optimally in busy oncology practices.
منابع مشابه
A changing paradigm for cancer treatment: the advent of new oral chemotherapy agents.
The development of numerous oral chemotherapy agents has led to a new paradigm in cancer treatment. Oral chemotherapy can be self-administered conveniently, so patients with cancer can receive their treatments in their homes instead of in a supervised and controlled healthcare environment. Cancer now is recognized as a treatable chronic disease, and new oral chemotherapy agents have been develo...
متن کاملEffective oral chemotherapy for breast cancer: pillars of strength.
Traditionally, anticancer therapy has been dominated by intravenous drug therapy. However, oral agents provide an attractive approach to chemotherapy and use of oral treatments is increasing. We discuss the benefits and challenges of oral chemotherapy from the perspectives of patients, healthcare providers and healthcare funders. Important issues include patient preference, efficacy, compliance...
متن کاملIncrease in oral cancer drugs raises thorny issues for oncology practices.
T he recent announcement of the prestigious 2009 Lasker clinical research award to the developers of imatinib (Gleevec) recognizes the advent of a new generation of targeted therapies, many of them taken as pills, that have transformed cancer treatment for many patients. In the last 5 – 10 years, oral agents such as gefitinib, erlotinib, lapatinib, and capecit abine have followed imatinib. And ...
متن کاملKnowledge of oral cancer and screening practices of primary care providers at Federally Qualified Health Centers.
OBJECTIVES Primary care providers (PCPs) who worked in Federally-Qualified Health Centers (FQHC) in Michigan were surveyed to assess their knowledge level and practices related to screening and preventing oral cancer. METHODS A questionnaire was developed with the assistance of dental and medical experts, and revised through focus groups. The questionnaire included one case scenario describin...
متن کاملSafe chemotherapy and targeted therapy for treating locally advanced NPC in a G6PD-deficient patient: case report and literature review
The article was first report a case of a 32-year-old female with NPC that is G6PD-deficient. The patient completed induction chemotherapy and concomitant chemoradiotherapy successfully. The patient experienced grade 1 neutropenia , grade 1 diarrhea, and grade 2 acne-like skin reactions during the three cycles of induction chemotherapy. Grade 1 neutropenia, grade 1 diarrhea, grade 2 oral mucosi...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- Clinical journal of oncology nursing
دوره 7 6 Suppl شماره
صفحات -
تاریخ انتشار 2003